Status:
COMPLETED
Central Aspects of Pain in Rheumatoid Arthritis
Lead Sponsor:
University of Nottingham
Collaborating Sponsors:
Versus Arthritis
Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to measure the psychometric properties of a newly developed Central Aspects of Pain in Rheumatoid Arthritis (CAP-RA) questionnaire, and investigate the ability of this questionnaire t...
Detailed Description
Persistent pain and fatigue are prevalent and disabling symptoms in people with Rheumatoid Arthritis, even in the absence of active inflammation. The investigators believe that these symptoms may be a...
Eligibility Criteria
Inclusion
- Adult (age≥18y) of any sex and ethnicity.
- Satisfy EULAR criteria for RA.
- Active RA, as defined as DAS28 ≥3.2 at baseline visit
Exclusion
- Unable to give informed consent.
- Insufficient understanding of spoken or written English to comply with the requirements of the study protocol
- Unable or unlikely to complete the proposed 12-week study follow up (eg. moving house, terminal diagnosis, current or planned pregnancy).
- Active comorbidity (e.g. uncontrolled diabetes mellitus, cancer, infection) requiring changes in medical treatment at baseline
- Major active psychiatric condition (e.g. major depression)
- Inability to meet the requirements of clinical assessments
Key Trial Info
Start Date :
August 11 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT04515589
Start Date
August 11 2021
End Date
September 30 2023
Last Update
December 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherwood Forest Hospitals NHS Foundation Trust
Mansfield, Nottinghamshire, United Kingdom